These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2013245)

  • 41. [An attempt to use ofloxacin in patients with mucoviscidosis].
    Chuchalin AG; Sokolov AS; Apul'tsina ID; GUgutsidze EN; Kuchkina NV; Samsonova MV
    Antibiot Khimioter; 1996; 41(9):43-6. PubMed ID: 9005785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ofloxacin versus parenteral therapy for chronic osteomyelitis.
    Gentry LO; Rodriguez-Gomez G
    Antimicrob Agents Chemother; 1991 Mar; 35(3):538-41. PubMed ID: 2039205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities.
    Hafkin B; Kaplan N; Murphy B
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1695-701. PubMed ID: 26711777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parenteral followed by oral ofloxacin for nosocomial pneumonia and community-acquired pneumonia requiring hospitalization.
    Gentry LO; Rodriguez-Gomez G; Kohler RB; Khan FA; Rytel MW
    Am Rev Respir Dis; 1992 Jan; 145(1):31-5. PubMed ID: 1731595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Stepdown ofloxacin therapy in bronchopulmonary diseases].
    Nonikov VE; Lenkova NI; Makarova OV; Ritchik LA
    Antibiot Khimioter; 1996; 41(9):50-2. PubMed ID: 9005787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial therapy of skin and soft tissue infection in children.
    Brook I
    J Am Podiatr Med Assoc; 1993 Jul; 83(7):398-405. PubMed ID: 8350252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of skin and soft tissue infections with cefadroxil, a new oral cephalosporin.
    Cordero A
    J Int Med Res; 1976; 4(3):176-8. PubMed ID: 1026545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Chronic osteitis--modern therapy].
    Vittver V; Ketterl' R
    Antibiot Khimioter; 1996; 41(9):57-9. PubMed ID: 9005789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and tolerability of linezolid in treating severe skin and soft tissue infections caused by Gram-positive pathogens.
    Chen YS; Lee SC; Kim WJ
    J Formos Med Assoc; 2004 May; 103(5):349-54. PubMed ID: 15216400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral levofloxacin in the treatment of community-acquired pneumonia.
    Nicodemo AC; Lima Nicodemo E; Idrahim KY
    Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single dose of ofloxacin treatment in women with dysuria and frequency.
    Simşek F; Dillioğlugil O; Ilker Y; Akdaş A
    Int Urol Nephrol; 1993; 25(3):249-54. PubMed ID: 8225825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(6):433-45. PubMed ID: 1663466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The dose-response study of sparfloxacin against skin and soft tissue structure infections in the field of surgery].
    Nakayama I; Yamaji E; Kawamura H; Kawaguchi H; Akieda Y; Suzuki T; Watanabe T; Itokawa K
    Jpn J Antibiot; 1993 Aug; 46(8):706-25. PubMed ID: 8230738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cutaneous infection by Mycobacterium fortuitum biovariant "third group"--a case report and bacteriological examination of the isolate].
    Fujimoto W; Kanzaki H; Fujiwara H; Arata J
    Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1173-81. PubMed ID: 2273580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of community-acquired pneumonia with ofloxacin.
    Youngchaiyud P; Permpikul C; Thamlikitkul V; Charoenratanakul S; Nana A
    J Med Assoc Thai; 1991 Feb; 74(2):61-5. PubMed ID: 2056259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral ofloxacin: a critical review of the new drug application.
    Sanders WE
    Clin Infect Dis; 1992 Feb; 14(2):539-54. PubMed ID: 1554843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of skin and soft-tissue infections with cefsulodin.
    Mogabgab WJ
    Rev Infect Dis; 1984; 6 Suppl 3():S721-7. PubMed ID: 6400534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multicenter open-label study of parenteral ofloxacin in treatment of pyelonephritis in adults.
    Cox CE; Gentry LO; Rodriguez-Gomez G
    Urology; 1992 May; 39(5):453-6. PubMed ID: 1580038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imipenem versus standard therapy in the treatment of serious soft tissue infection.
    Gould IM; Hudson M; Morris J; Page G; Douglas JG; Smith CC; Reid TM
    Drugs Exp Clin Res; 1988; 14(8):555-8. PubMed ID: 3073933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.